Category: Federal

Premier Asks Court to Reject HRSA’s Defense of 340B Hospital Drug Purchasing Restrictions Policy, Requests Oral Arguments

June 5, 2025 Shannon Young, Associate Editor/Senior Writer Views

Premier again asked a Washington D.C. federal court to strike down a HRSA policy that restricts how certain 340B hospitals can purchase initial drug inventory.

A major group purchasing organization (GPO) recently urged a Washington D.C. federal court to reject the federal government’s defense of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Roundup: Drugmakers File Briefs in 5th Circuit Appeals Case, Updates in Utah and Nebraska

June 5, 2025 Shannon Young, Associate Editor/Senior Writer Views

Key briefs were filed in litigation on contract pharmacy access laws in Louisiana, Utah and Nebraska.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Stakeholders Offer Mixed Views on Trump’s Plan to Move Drug Pricing Program to CMS

June 3, 2025 Shannon Young, Associate Editor/Senior Writer Views

340B advocates and stakeholders offered mixed reactions to President Donald Trump's HHS budget request, which called for moving the 340B program to CMS.

340B stakeholders and attorneys offered mixed initial reactions this week to President Donald Trump’s proposal to move the 340B program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Trump’s Full 2026 Budget Request Would Shift 340B Program from HRSA to CMS, Maintain Current OPA Funding

May 30, 2025 William Newton, Associate Editor/Senior Writer Views

CMS would assume oversight of the 340B program under the White House’s full fiscal year 2026 budget proposal released May 30.

President Donald Trump’s fiscal year 2026 budget request released yesterday calls for moving control of the 340B program away from [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

First 340B Administrative Dispute Resolution Panel Decision Sides with Drug Industry

May 30, 2025 William Newton, Associate Editor/Senior Writer Views

The first decision was recently issued under HRSA's revised 340B Administrative Dispute Resolution process.

The first published decision under the revamped 340B Administrative Dispute Resolution (ADR) process sided with the drug industry, marking a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Katie Miller, Key Player in Anti-340B ‘Dark Money’ Campaign, Leaves White House Adviser Role

May 30, 2025 Shannon Young, Associate Editor/Senior Writer Views

Katie Miller, a key figure in a dark money anti-340B campaign, has left her role as a White House adviser.

A Trump administration adviser and key figure in a dark money effort to tie the 340B program to immigration growth, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Cassidy Says 340B ‘Was Never Meant to be Part of an Earnings Call’

May 30, 2025 Shannon Young, Associate Editor/Senior Writer Views

U.S. Sen. Bill Cassidy (R-La.) discussed the 340B program in a recent interview with Punchbowl News.

A key U.S. senator on 340B policy continued to raise concerns this week about the current state of the drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two Drugmakers Appeal Federal District Judge’s 340B Rebate Ruling in Favor of HHS

May 30, 2025 William Newton, Associate Editor/Senior Writer Views

Two drugmakers are appealing a Washington, D.C. federal district judge's ruling against unilateral 340B rebate models.

Novartis and Bristol Myers Squibb (BMS) are both asking a federal appeals court to overturn a lower court’s ruling that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Column: Battlefront Shifts from Contract Pharmacies to Rebates

May 30, 2025 Ted Slafsky, Publisher & CEO Views

Ted Slafsky, publisher and CEO of 340B Report, writes on drugmaker efforts to convert upfront 340B discounts to a rebate model.

By the first week of June, we should have a better sense of how the Trump administration plans to address [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Defends 340B Hospital Drug Purchasing Restrictions Policy, Asks Federal Court to Reject Premier’s Challenge

May 28, 2025 Shannon Young, Associate Editor/Senior Writer Views

HHS attorneys recently urged a Washington D.C. federal court to uphold a 2013 HRSA policy and reject Premier's claim that it unlawfully restricts how certain 340B hospitals can purchase initial drug inventory.

The Trump administration this month urged a Washington D.C. federal court to uphold a 2013 Health Resources and Services Administration [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live